Overactive Bladder Syndrome

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over

Study of V117957 in Overactive Bladder Syndrome

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects

Cycling Study With the Axonics System

Use of Repris Needle in Bladder Injection

Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol

OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome